🇺🇸 FDA
Pipeline program

JZP598, TRASTUZUMAB EMTANSINE, DOCETAXEL , TRASTUZUMAB , PACLITAXEL , PACLITAXEL ALBUMIN-BOUND, PERTUZUMAB , CARBOPLATIN , TRASTUZUMAB EMTANSINE

EmpowHER 208

Phase 2 small_molecule active

Quick answer

JZP598, TRASTUZUMAB EMTANSINE, DOCETAXEL , TRASTUZUMAB , PACLITAXEL , PACLITAXEL ALBUMIN-BOUND, PERTUZUMAB , CARBOPLATIN , TRASTUZUMAB EMTANSINE for HER2-positive breast cancer is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals Ireland Limited
Indication
HER2-positive breast cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials